Lista de obras -

A framework for assessing outcomes from newborn screening: on the road to measuring its promise

artículo científico publicado en 2016

AB010. Newborn screening worldwide: when and where is molecular testing a part of the screening protocol

artículo científico publicado en 2015

An update on public health newborn screening activities. Introduction

artículo científico publicado en 2010

Application of Molecular Genetics in Public Health: Improved Follow-up in a Neonatal Hemoglobinopathy Screening Program ⬇️

artículo científico publicado el 1 de junio de 1994

Assuring clinical genetic services for newborns identified through U.S. newborn screening programs

artículo científico publicado en 2007

Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States

artículo científico publicado en 2011

Challenges and opportunities in establishing and maintaining newborn screening systems

artículo científico publicado en 2003

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

scientific article published on 01 July 2011

Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states

artículo científico publicado en 2008

Computerized newborn screening in texas?A multiple microcomputer approach ⬇️

artículo científico publicado el 1 de abril de 1988

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder

article

Considerations in choosing screening conditions: one (US) approach.

artículo científico publicado en 2008

Consolidating newborn screening efforts in the Asia Pacific region : Networking and shared education

artículo científico publicado en 2012

Current status of newborn screening worldwide: 2015.

artículo científico

DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up

artículo científico publicado en 2003

Data integration and warehousing: coordination between newborn screening and related public health programs.

artículo científico publicado en 2003

Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study

artículo científico

Effect of laboratory practices on the incidence rate of congenital hypothyroidism

artículo científico publicado en 2010

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

artículo científico publicado en 2020

Ethical, legal and social issues in newborn screening in the United States.

artículo científico publicado en 2003

Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents

artículo científico publicado en 2009

Financing newborn screening systems: US experience

artículo científico publicado en 2008

Financing newborn screening: sources, issues, and future considerations

artículo científico publicado en 2007

Financing state newborn screening programs: sources and uses of funds

artículo científico publicado en 2006

Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program

artículo científico publicado el 1 de marzo de 1992

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

artículo científico publicado en 2010

Hemoglobin Cubujuqui (α141 ARG-SER): Functional Consequences of the Alteration of the C-Terminus of the αChain of Hemoglobin ⬇️

artículo científico publicado el 1 de enero de 1981

Hemoglobin Fannin-Lubbock [alpha2 beta 2 119 (GH2) Gly replaced by Asp]. A new hemoglobin variant at the alpha1 beta 1 contact

artículo científico publicado el 22 de diciembre de 1976

Hemoglobin P Nilotic in a Mexican-American Family ⬇️

artículo científico publicado el 1 de enero de 1978

Hemoglobin Tarrant: alpha126(H9) Asp leads to Asn. A new hemoglobin variant in the alpha1beta1 contact region showing high oxygen affinity and reduced cooperativity ⬇️

artículo científico publicado el 22 de febrero de 1977

Hemoglobins Austin and Waco: two hemoglobins with substitutions in the alpha 1 beta 2 contact region ⬇️

artículo científico publicado el 1 de febrero de 1977

History and current status of newborn screening for hemoglobinopathies

artículo científico publicado en 2010

History of the International Society for Neonatal Screening.

artículo científico publicado en 2003

Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening

artículo científico publicado en 2012

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning

artículo científico publicado en 2014

Including ELSI research questions in newborn screening pilot studies

scientific article published on 13 August 2018

Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children

artículo científico publicado en 2012

Introduction

Long-term follow-up data collection and use in state newborn screening programs

artículo científico publicado en 2007

Naming and counting disorders (conditions) included in newborn screening panels

artículo científico publicado en 2006

National evaluation of US newborn screening system components

artículo científico publicado en 2006

Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).

scientific article published on April 2010

Newborn Screening for Congenital Hypothyroidism in India: Let's Just Do It!

scientific article published on 01 April 2019

Newborn dried blood spot screening: residual specimen storage issues

artículo científico publicado en 2012

Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments

scientific article published on 01 December 2008

Newborn screening for hyperargininemia due to arginase 1 deficiency

artículo científico publicado en 2017

Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades

artículo científico publicado en 2015

Newborn screening in North America

artículo científico publicado en 2007

Newborn screening in the Asia Pacific region

artículo científico publicado en 2007

Newborn screening in the developing countries

scientific article published on 01 December 2018

Newborn screening progress in developing countries--overcoming internal barriers

scientific article published on April 2010

Newborn screening: rationale for a comprehensive, fully integrated public health system

artículo científico publicado en 2002

Newborn screening: the role of the obstetrician

artículo científico publicado en 2002

Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories

artículo científico publicado en 2003

Parental permission for pilot newborn screening research: guidelines from the NBSTRN.

artículo científico publicado en 2014

Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement

scientific article published on 11 December 2020

Preliminary Investigation of the Use of Dried-Blood Spots for the Assessment ofin UteroExposure to Environmental Pollutants ⬇️

artículo científico publicado el 1 de agosto de 1997

Qualitative evaluation of the reagin screen test ⬇️

artículo científico publicado el 1 de julio de 1976

Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia ⬇️

artículo científico publicado el 1 de abril de 1998

Standardizing newborn screening results for health information exchange.

artículo científico publicado en 2010

Status of newborn screening programs in the United States

artículo científico publicado en 2006

Syphla-Chek: a qualitative study ⬇️

artículo científico publicado el 1 de junio de 1977

Tracking clinical genetic services for newborns identified through newborn dried bloodspot screening in the United States-lessons learned

artículo científico publicado en 2011

Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas

artículo científico publicado en 2010

Understanding newborn screening system issues with emphasis on cystic fibrosis screening

artículo científico publicado en 2005

Lista de obras de

A framework for assessing outcomes from newborn screening: on the road to measuring its promise

AB010. Newborn screening worldwide: when and where is molecular testing a part of the screening protocol

An update on public health newborn screening activities. Introduction

Application of Molecular Genetics in Public Health: Improved Follow-up in a Neonatal Hemoglobinopathy Screening Program ⬇️

Assuring clinical genetic services for newborns identified through U.S. newborn screening programs

Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States

Challenges and opportunities in establishing and maintaining newborn screening systems

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states

Computerized newborn screening in texas?A multiple microcomputer approach ⬇️

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder

Considerations in choosing screening conditions: one (US) approach.

Consolidating newborn screening efforts in the Asia Pacific region : Networking and shared education

Current status of newborn screening worldwide: 2015.

DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up

Data integration and warehousing: coordination between newborn screening and related public health programs.

Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study

Effect of laboratory practices on the incidence rate of congenital hypothyroidism

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

Ethical, legal and social issues in newborn screening in the United States.

Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents

Financing newborn screening systems: US experience

Financing newborn screening: sources, issues, and future considerations

Financing state newborn screening programs: sources and uses of funds

Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

Hemoglobin Cubujuqui (α141 ARG-SER): Functional Consequences of the Alteration of the C-Terminus of the αChain of Hemoglobin ⬇️

Hemoglobin Fannin-Lubbock [alpha2 beta 2 119 (GH2) Gly replaced by Asp]. A new hemoglobin variant at the alpha1 beta 1 contact

Hemoglobin P Nilotic in a Mexican-American Family ⬇️

Hemoglobin Tarrant: alpha126(H9) Asp leads to Asn. A new hemoglobin variant in the alpha1beta1 contact region showing high oxygen affinity and reduced cooperativity ⬇️

Hemoglobins Austin and Waco: two hemoglobins with substitutions in the alpha 1 beta 2 contact region ⬇️

History and current status of newborn screening for hemoglobinopathies

History of the International Society for Neonatal Screening.

Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning

Including ELSI research questions in newborn screening pilot studies

Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children

Introduction

Long-term follow-up data collection and use in state newborn screening programs

Naming and counting disorders (conditions) included in newborn screening panels

National evaluation of US newborn screening system components

Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).

Newborn Screening for Congenital Hypothyroidism in India: Let's Just Do It!

Newborn dried blood spot screening: residual specimen storage issues

Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments

Newborn screening for hyperargininemia due to arginase 1 deficiency

Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades

Newborn screening in North America

Newborn screening in the Asia Pacific region

Newborn screening in the developing countries

Newborn screening progress in developing countries--overcoming internal barriers

Newborn screening: rationale for a comprehensive, fully integrated public health system

Newborn screening: the role of the obstetrician

Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories

Parental permission for pilot newborn screening research: guidelines from the NBSTRN.

Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement

Preliminary Investigation of the Use of Dried-Blood Spots for the Assessment ofin UteroExposure to Environmental Pollutants ⬇️

Qualitative evaluation of the reagin screen test ⬇️

Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia ⬇️

Standardizing newborn screening results for health information exchange.

Status of newborn screening programs in the United States

Syphla-Chek: a qualitative study ⬇️

Tracking clinical genetic services for newborns identified through newborn dried bloodspot screening in the United States-lessons learned

Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas

Understanding newborn screening system issues with emphasis on cystic fibrosis screening